Measuring the effect of inter-study variability on estimating prediction error.

Area of Science:

• Biomedical informatics
• Genomics
• Translational medicine

Background:

• Biomarker discovery frequently yields molecular signatures with promising predictive performance that fail to translate to clinical settings.
• This failure is often attributed to inconsistent classification performance across studies, stemming from technical batch-effects and biological variations.
• These sources of variability persist even with advanced data collection technologies.

Purpose of the Study:

• To quantify the impact of combined "study-effects" on disease signature predictive performance.
• To compare the performance estimates derived from randomized cross-validation (RCV) and inter-study validation (ISV).
• To establish a method for estimating when sufficient data diversity is achieved for reliable biomarker translation.

Main Methods:

• Quantified "study-effects" by comparing RCV (random sample subsets) and ISV (entire studies excluded for testing).
• Assessed how RCV's assumption of identically distributed data differs from ISV's approach.
• Measured the RCV-ISV performance difference as a function of the number of studies to quantify study-effect influence.

Main Results:

• Analyzed gene expression data from 1,470 microarray and 769 RNA-seq samples across multiple lung phenotypes and studies.
• Observed a greater RCV-ISV performance discrepancy in phenotypes with fewer contributing studies.
• Demonstrated that ISV performance converges towards RCV performance as data from more studies are integrated.

Conclusions:

• Examining the rate at which ISV performance approaches RCV performance with increasing study numbers provides an estimate of sufficient data diversity.
• This approach helps determine when a molecular signature is likely to translate to new clinical settings without significant accuracy loss.
• Highlights the importance of inter-study validation for assessing the robustness and generalizability of biomarkers.